apo e4

From Aaushi
Jump to navigation Jump to search

Introduction

Allelic form of apo E

Structure

Pathology

Laboratory

More general terms

Additional terms

References

  1. Mendelian Inheritance in Man (1990) MIM#107741
  2. Strittmatter WJ et al Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977-81 PMID: https://www.ncbi.nlm.nih.gov/pubmed/8446617
  3. 3.0 3.1 Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 2352
  4. 4.0 4.1 Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001 Apr;81(2):741-66. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11274343
  5. 5.0 5.1 Rutlege JC, UC Davis Dept of Medicine Grand Rounds, Aug 2, 2007
  6. 6.0 6.1 6.2 Altmann A et al Sex modifies the APOE-related risk of developing Alzheimer disease. Annals of Neurology. April 14, 2014 http://onlinelibrary.wiley.com/doi/10.1002/ana.24135/abstract
  7. 7.0 7.1 7.2 Geriatric Review Syllabus, 9th edition (GRS9) Medinal-Walpole A, Pacala JT, Porter JF (eds) American Geriatrics Society, 2016
    Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022
  8. Bu G. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009 May;10(5):333-44. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19339974 Free PMC Article
  9. Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013 Feb;9(2):106-18. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23296339 Free PMC Article
  10. 10.0 10.1 Ward A, Crean S, Mercaldi CJ et al Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology. 2012;38(1):1-17. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22179327 Free Article
  11. 11.0 11.1 Shaw P, Lerch JP, Pruessner JC et al Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol. 2007 Jun;6(6):494-500. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17509484
  12. 12.0 12.1 Kim R, Park S, Yoo D et al. on Association of physical activity and APOE genotype with longitudinal cognitive change in early PD. Neurology 2021 Mar 31; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/33790041 https://n.neurology.org/content/early/2021/03/31/WNL.0000000000011852
  13. 13.0 13.1 Lane-Donovan C, Herz J. ApoE, ApoE Receptors, and the synapse in Alzheimer's disease. Trends Endocrinol Metab. 2017;28(4):273-284 PMID: https://www.ncbi.nlm.nih.gov/pubmed/28057414 PMCID: PMC5366078Free PMC article https://www.cell.com/trends/endocrinology-metabolism/fulltext/S1043-2760(16)30170-9
  14. 14.0 14.1 Uddin MS, Kabir MT, Al Mamun A et al. APOE and Alzheimer's disease: evidence mounts that targeting APOE4 may combat Alzheimer's pathogenesis. Mol Neurobiol. 2019;56(4):2450-2465 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30032423 https://link.springer.com/article/10.1007/s12035-018-1237-z
  15. 15.0 15.1 Zhao N, Liu CC, Qiao W, et al. Apolipoprotein E, receptors, and modulation of Alzheimer's disease. Biol Psychiatry. 2018;83(4):347-357 PMID: https://www.ncbi.nlm.nih.gov/pubmed/28434655 PMCID: PMC5599322Free PMC article https://www.biologicalpsychiatryjournal.com/article/S0006-3223(17)31358-6/fulltext